Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
grants_gov PAR-25-226 · HHS-NIH11
| Status | open |
|---|---|
| Opens | 22 Nov 2024 |
| Deadline | 19 Nov 2026 — 67 days |
| Action | posted |
| Official page | https://www.grants.gov/search-results-detail/357343… |
| Fetched | 2026-09-13 04:00:43+00:00 |
You are reading one call. 1,385 are open right now.
A search matches words. It cannot know what your institution works on. Give the name and every open call is ranked against it — this one included.
Free · no account · nothing stored that identifies you
Found one worth pursuing?
Finding the call is the easy half. Scientific Network Management is the grant-writing practice behind this radar — 13 years of writing and managing EU-funded research projects, including two EuropeAid technical assistance contracts building biotechnology centres in Türkiye as Team Leader.
Proposal writingHorizon Europe, EU4Health, EuropeAid. Concept
to submission, or a review of a draft you already have.
Consortium buildingFinding and approaching the partners a call
requires, and holding the consortium together through drafting.
Project managementRunning the project after the award —
reporting, deliverables, coordination, audits.
Talk to us What SNM does No obligation, and nothing here is conditional on using us — the radar stays free and complete either way.